Search results
Iron Deficiency in LVAD Patients
Author(s):
William Herrik Nielsen
,
Finn Gustafsson
Added:
1 year ago
Review Article
Jan Steffel
Research Area(s) / Expertise:
Author
Expertise
Felix Mahfoud
Job title: Professor of Cardiology and Chairman of the Department of Cardiology
Author
Added:
3 months ago
Source:
Radcliffe Cardiology
A novel cardiac myosin agonist, danicamtiv, has shown favourable safety and efficacy signals in patients with dilated cardiomyopathy (DCM), particularly in those with specific genetic variants, according to results from a phase 2a open-label trial.¹ Precision therapies for DCM are currently lacking, despite its diverse clinical manifestations often linked to underlying genetic causes.²Danicamtiv…
View more
Abbott Laboratories
Supplier
Author(s):
Giuseppe Rosano
,
John R Teerlink
,
Koichiro Kinugawa
Added:
11 months ago
This comprehensive video series has been designed to enhance your understanding of heart failure (HF) management. Through expert discussions, we explore the real-world adoption of novel guideline-directed medical therapies (GDMTs) and their impact on patient care. We also delve into the benefits of natriuretic peptide (NP) testing, highlighting how it aids in more accurate and rapid diagnosis,…
View more
Added:
5 months ago
Source:
Radcliffe Cardiology
Natriuretic peptides are key biomarkers used to risk-stratify patients with heart failure (HF), but current guideline thresholds do not typically account for body mass index (BMI).¹ A new pooled analysis suggests that these fixed thresholds may underestimate risk in patients with HF and higher BMI, questioning the one-size-fits-all approach.²This study was a participant-level pooled analysis of…
View more
Antonio Colombo
Job title: Senior Consultant and Director of the Cardiac Catheterization Laboratory
Author
Aaron Isaacs
Author
Abhishek Joshi
Job title: Cardiac Imaging Fellow
Author